MEG
TECH icon

Millstone Evans Group’s Bio-Techne TECH Stock Holding History

Millstone Evans Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.9K Hold
423
– – 0.02% 450
2026
Q1 		$22.1K Buy
+423
New +$25.4K 0.01% 468
2025
Q4 		– Sell
-180
Closed -$10K – 874
2025
Q3 		$10K Buy
+180
New +$9.64K 0.01% 535
2025
Q2 		– Sell
-97
Closed -$5.69K – 814
2025
Q1 		$5.69K Buy
+97
New +$6.57K ﹤0.01% 586

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Millstone Evans Group's TECH Position: Q2 2026 in Review

Millstone Evans Group held its Bio-Techne (TECH) position steady in Q2 2026 at 423 shares worth $29.9K. The position accounts for 0.02% of the portfolio, ranked #450.

Millstone Evans Group first reported a position in TECH in Q1 2025 and has held it in 4 quarters since. 438 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Millstone Evans Group held 423 shares of Bio-Techne worth $29.9K as of Q2 2026.
  • Millstone Evans Group left its Bio-Techne share count unchanged in Q2 2026.
  • Bio-Techne made up 0.02% of Millstone Evans Group's portfolio in Q2 2026, its #450 holding.
  • Millstone Evans Group first reported a position in Bio-Techne in Q1 2025 and has held it in 4 quarters since.
  • 438 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.